- Home
- MNDR vs PRPH Comparison
MNDR vs PRPH Comparison
Compare MNDR & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDR
- PRPH
- Stock Information
- Founded
- MNDR 2016
- PRPH 1989
- Country
- MNDR Singapore
- PRPH United States
- Employees
- MNDR N/A
- PRPH N/A
- Industry
- MNDR
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- MNDR
- PRPH Health Care
- Exchange
- MNDR Nasdaq
- PRPH Nasdaq
- Market Cap
- MNDR 14.7M
- PRPH 14.7M
- IPO Year
- MNDR 2024
- PRPH 1997
- Fundamental
- Price
- MNDR $0.29
- PRPH $0.75
- Analyst Decision
- MNDR
- PRPH Strong Buy
- Analyst Count
- MNDR 0
- PRPH 1
- Target Price
- MNDR N/A
- PRPH $11.00
- AVG Volume (30 Days)
- MNDR 1.8M
- PRPH 296.6K
- Earning Date
- MNDR 12-02-2024
- PRPH 11-13-2024
- Dividend Yield
- MNDR N/A
- PRPH N/A
- EPS Growth
- MNDR N/A
- PRPH N/A
- EPS
- MNDR N/A
- PRPH N/A
- Revenue
- MNDR $13,968,535.00
- PRPH $12,753,000.00
- Revenue This Year
- MNDR $188,831.77
- PRPH $36.93
- Revenue Next Year
- MNDR $76.44
- PRPH $132.05
- P/E Ratio
- MNDR N/A
- PRPH N/A
- Revenue Growth
- MNDR 77.38
- PRPH N/A
- 52 Week Low
- MNDR $0.23
- PRPH $0.66
- 52 Week High
- MNDR $29.50
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- MNDR N/A
- PRPH 19.28
- Support Level
- MNDR N/A
- PRPH $0.72
- Resistance Level
- MNDR N/A
- PRPH $0.83
- Average True Range (ATR)
- MNDR 0.00
- PRPH 0.13
- MACD
- MNDR 0.00
- PRPH -0.05
- Stochastic Oscillator
- MNDR 0.00
- PRPH 7.45
About MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. They provide their services on its MaNaDr platform, which is accessible via their mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users. The company's revenues are derived mainly from the provision of telemedicine and other services, sale of medicine and medical devices.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.